Patrick Walsh
Corporate Officer/Principal bei IMMUNIC, INC.
Profil
Patrick Walsh is currently the Chief Business Officer at Immunic, Inc. He previously worked as the Director of Business Development at Akebia Therapeutics, Inc. and as the Head of Corporate Development at AVEO Pharmaceuticals, Inc. Walsh received his undergraduate degree from Colby College and his graduate and Masters of Business Administration degrees from the University of Michigan.
Aktive Positionen von Patrick Walsh
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNIC, INC. | Corporate Officer/Principal | 14.10.2021 |
Ehemalige bekannte Positionen von Patrick Walsh
| Unternehmen | Position | Ende |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| AKEBIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Patrick Walsh
| Colby College | Undergraduate Degree |
| University of Michigan | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
